Correlates of controlled hypertension in indigent, inner-city hypertensive patients

Journal of General Internal Medicine

Volumn 12, Issue 1, 1997, Pages 7-14

  Ahluwalia, Jasjit S ^a,b   McNagny, Sally E ^a,b   Rask, Kimberly J ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

access to care; hypertension; inner city patients; regular source of care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SOCIOECONOMICS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DATA INTERPRETATION, STATISTICAL; FEMALE; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HOSPITALS, URBAN; HUMANS; HYPERTENSION; MALE; MEDICAID; MEDICAL INDIGENCY; MIDDLE AGED; MINORITY GROUPS; PATIENT EDUCATION; UNITED STATES;

EID: 0031047930     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11606-006-0002-6     Document Type: Article

References (58)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-83.
2. Rivo ML, Saultz JW, Wartman SA, DeWitt TG. Defining the generalist physician's training. JAMA. 1994;271:1499-504.
3. Calhoun DA, Oparil S. Hypertensive crisis since FDR - a partial victory. N Engl J Med. 1995;332:1029-30.
4. Whelton PK, Brancati FL. Hypertension management in populations. Clin Exp Hypertens. 1993;15:1147-56.
5. Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health. 1988;78:636-40.
6. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men - a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-21.
7. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Hypertension. 1995;25:305-13.
8. Moorman PG, Hames CG, Tyroler HA. Socioeconomic status and morbidity and mortality in hypertensive blacks. In: Saunders E, ed. Cardiovascular Diseases in Blacks, Philadelphia, Pa: FA Davis Co; 1991:179-92.
9. Kaplan NM. Ethnic aspects of hypertension. Lancet. 1994;344:450-1.
10. Keeler EB, Brook RH, Goldberg GA, Kamberg CJ, Newhouse JP. How free care reduced hypertension in the health insurance experiment. JAMA. 1985;254:1926-31.
11. Saunders E. Tailoring treatment to minority patients. Am J Med. 1990;88(suppl 3B):21S-23S.
12. Haywood J. Hypertension in minority populations. Am J Med. 1990;88(suppl 3B):17S-20S.
13. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CG. Financial cost as an obstacle to hypertension therapy. Am J Public Health. 1986;76:1105-8.
14. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-8.
15. U.S. Dept. Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: Government Printing Office; 1991.
16. Aday LA, Anderson R. A framework for the study of access to medical care. Health Serv Res. Fall 1974: 208-20.
17. Gonzalez-Fernandez RA, Rivera M, Torres D, Quiles J, Jackson A. Usefulness of a systemic hypertension in-hospital educational program. Am J Cardiol. 1990;65:1384-6.
18. Farquhar JW, Fortmann SP, Flora JA, et al. Effects of community-wide education on cardiovascular disease risk factors - the Stanford Five-City Project. JAMA. 1990;264:359-65.
19. Levine DM, Green LW, Deeds SG, Chwalow J, Russell RP, Finlay J. Health education for hypertensive patients. JAMA. 1979;241:1700-3.
20. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776-81.
21. Lurie N, Ward NB, Shapiro MF, Brook RH. Termination from MediCal. Does it affect health? N Engl J Med. 1984;311:482-4.
22. Fihn SD, Wicher JB. Withdrawing routine outpatient medical services: effects on access and health. J Gen Intern Med. 1988;3:356-62.
23. Brook RH, Ware JE, Rogers WH, et al. Does free care improve adults health? Results from a randomized controlled trial. N Engl J Med. 1983;309:1426-34.
24. Woolhandler S, Himmelstein DU. Reverse targeting of preventive care due to lack of health insurance. JAMA. 1988;259:2872-4.
25. Moy E, Bartman BA, Weir MR. Access to hypertensive care: effects of income, insurance and source of care. Arch Intern Med. 1995; 155:1497-1502.
26. Haynes RB. Strategies to improve compliance with referrals, appointments, and prescribed medical regimens. In: Sackett DL, Haynes RB, eds. Compliance in Health Care. Baltimore, Md: The Johns Hopkins University Press; 1979:121-43.
27. Reif MC, Carter VL. The retail cost of antihypertensive therapy - physician and patient as educated consumers. Am J Hypertens. 1994;7:571-5.
28. Stason WB. Cost and quality trade-offs in the treatment of hypertension. Hypertension. 1989;13(suppl I):I-145-8.
29. Braveman P, Schaaf VM, Egerter S, Bennett T, Schecter W. Insurance-related differences in the risk of ruptured appendix. N Engl J Med. 1994;331:444-9.
30. Baker DW, Stevens CD, Brook RH. Regular source of ambulatory care and medical care utilization by patients presenting to a public hospital emergency department. JAMA. 1994;271:1909-12.
31. Kogan MD, Alexander GR, Teitelbaum MA, Jack BW, Kotelchuck M, Pappas G. The effect of gaps in health insurance on continuity of a regular source of care among preschool-aged children in the United States. JAMA. 1995;274:1429-35.
32. Stoddard JJ, St Peter RF, Newacheck PW. Health insurance status and ambulatory care for children. N Engl J Med. 1995;330:1421-5.
33. Williams MV, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274:1677-82.
34. Burch GE, DePasquale NP. Primer of Clinical Measurement of Blood Pressure. St. Louis, Mo: CV Mosby Co; 1962.
35. Reeves RA. Does this patient have hypertension? JAMA. 1995; 273:1211-8.
36. Chyba MM, Washington LR. Vital and health statistics: questionnaires from the National Health Interview Survey, 1985-89. National Center for Health Statistics. Vital Health Stat. 1993:1(31).
37. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care. 1988;26:724-35.
38. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-7.
39. Buchsbaum DG, Buchanan RG, Centor RM, Schnoll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 1991;115:774-7.
40. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates on nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607-11.
41. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
42. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info. 5.01b ed. Stone Mountain, Ga: USD, Inc.; 1990
43. SAS Institute Inc. SAS/STAT User's Guide. 6.0 ed. Cary. NC: SAS Institute Inc.; 1989.
44. Rask KJ, Williams MV, Parker RM, McNagny SE. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA. 1994;271:1931-3.
45. Daughtery SA. Hypertension Detection and Follow-up Program Cooperative Group. Description of enumerated and screened population. Hypertension. 1983;5(suppl IV):1-43.
46. Rocella EJ, Horan MJ. The National High Blood Pressure Education Program: measuring progress and assessing its impact. Health Psychol. 1988;7:297-303.
47. Wagner EH, Warner JT, Slome C. Medical care use and hypertension. Med Care. 1980;18:1241-50.
48. Centers for Disease Control, Adults taking action to control their blood pressure - United States, 1990. MMWR. 1994;43:509-11.
49. Strickland WJ, Hanson CM. Coping with the cost of prescription drugs. J Health Care Poor Underserved. 1996;7:50-63.
50. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologie management of hypertension in the United States. Arch Intern Med. 1995;155:829-37.
51. Shulman N, Cutter G, Daugherty R, et al. Correlates of attendance and compliance in the hypertension detection and follow-up program. Control Clin Trials. 1982;3:13-27.
52. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757-64.
53. Klein KE. Compliance and blood pressure control. Hypertension. 1988;11(suppl II):II/61-4.
54. The Medicaid Access Study Group. Access of Medicaid recipients to outpatient care. N Engl J Med. 1994;330:1426-30.
55. Perloff JD, Morris NM. Asking about the usual source of care - an appraisal of health care survey alternatives. Med Care. 1992; 30:950-7.
56. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol. 1982;116:114-22.
57. Monheit AC. Underinsured Americans: a review. Annu Rev Public Health. 1994;15:461-85.
58. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1768-74.